Organisation paid for research Program year 2020 Source: CMS Open Payments

Shettle Eye Research Incorporated

Neither a doctor nor a teaching hospital

Research payments

$20,158

3 payments

Through program year 2020, Shettle Eye Research Incorporated is reported as receiving $20,158 in research payments, across 3 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$6,145	1
2019	Research	$14,014	2

Breakdown

Who paid Research payments · program years 2019–2020

Shire North American Group Inc $14,014 2 payments
Takeda Pharmaceuticals U.S.A., Inc. $6,145 1 payment

Studies the money was for Research payments · program years 2019–2020

A Phase 3, Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of Shp640 Pvp-Iodine 0.6 and Dexamethasone 0.1 Ophthalmic Suspension in the Treatment of Adenoviral Conjunctivitis $8,507 1 payment
A Phase 3, Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of Shp640 (Pvp-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension in the Treatment of Adenoviral Conjunctivitis $6,145 1 payment
A Phase 3, Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of Shp640 Pvp-Iodine 0.6 and Dexamethasone 0.1 Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis $5,507 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.